This isn't your grandmother's tableware company. Courtesy of Rigby

A good tableware set comes into your life once in a lifetime — and usually that occasion is from a wedding registry. But a Houston entrepreneur wants to change that way of thinking.

Sara Kelly created her direct-to-consumer tableware brand called Rigby, which features handcrafted stoneware dishes, glassware, and a flatware line.

"With Rigby I want to encourage individuals in all life stages to feel at home with the present," says Kelly in a news release. "You shouldn't feel like you have to wait for a big lifetime event, like getting married or buying a house, to purchase tableware and other items that make your time at home more enjoyable."

Kelly, founder, tells InnovationMap that as a single professional she felt disconnected from the tableware industry, which she says is focused on wedding registries and unrealistic entertaining. After realizing that her friends felt the same way, Kelly saw an opportunity to start a business and the idea for Rigby was born in 2017. She launched the line just two years later in August.

"The reaction to the brand and the product has been great," says Kelly. "It's been so exciting for me to see that. At this point, we're focused on organic growth since we're so new."

The brand's pieces are crafted and hand-finished by professional craftspeople in Portugal. Kelly tells InnovationMap that she was inspired to source from the country following her travels in Europe where she purchased a few ceramic pieces. The company currently partners with three different factories across Portugal.

Drawn to the centuries-old heritage crafts of stoneware, glassware, and flatware production in Europe, Kelly tells InnovationMap that she knew that she wanted to partner with factories that incorporate a human touch into every step of the process.

Kelly, originally from the Southampton neighborhood in the Houston-area, moved back to the city six years ago. She tells InnovationMap that Houston's growing and supportive startup community was key to her decision to grow Ribgy into a national brand from the Lone Star state. Before launching Rigby, Kelly worked in product marketing for four years.

"Houston is a great market, and we're based here, so it's really important to me to have a presence in Houston," says Kelly. "Right now, I'm in the process of figuring out how the product can get in front of people here through pop-ups, and collaborations with other brands and influencers."

Rigby's stoneware includes mugs, dinner plates, salad plates, pasta bowls, and breakfast bowls, which are all available in off white, mint, charcoal-navy, and grey. Hand-blown glasses are available in a short and a tall design and each piece is unique. The 18/10 stainless steel flatware sets are available in polished stainless steel, satin black, satin gold, and satin copper finishes. Pricing for sets of four range from $48 to $64 for dishware, $56 to $64 for glassware, and $180 to $280 for flatware. Rigby's collection is available only online.

"I put a lot of thought into the design details of each piece and carefully considered how each piece feels in your hand," says Kelly. "The plates have an angled rim, which makes them easy to pick up and prevents food from spilling off the sides. The stoneware dishes feel substantial in your hand — not dainty or fragile — and stack on shelves nicely. Our flatware has a sleek, slightly rounded silhouette and feels comfortable when held. All of our items are dishwasher safe."

Kelly tells InnovationMap that Rigby's focus on craftsmanship and high quality products helps them stand out from their competitors. "We're also focused on people's real lives, so instead of the 'Instagram perfect' message, it's about how people live their lives everyday," says Kelly.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.